The optimal strategy with VIABAHN VBX covered stent for complex aort-iliac artery disease by endovascular procedure

The optimal strategy with VIABAHN VBX covered stent for complex aort-iliac artery disease by endovascular procedure - AVOCADO-II study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043416

Enrollment

120

Registered

2021-03-01

Start date

2020-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Peripheral artery disease (Rutherford category 2 to 6) 2) Endovascular procedure using VIABAHN VBX stents for aorto-iliac artery disease

Exclusion criteria

Exclusion criteria: no angiography case

Design outcomes

Primary

Measure	Time frame
One year primary patency	—

Secondary

Measure	Time frame
One year CD-TLR Procedual complication IVUS data	—

Countries

Japan

Contacts

Public ContactYusuke Tomoi

Kokura Memorial Hospital Cardiology

mbxtg263@ybb.ne.jp0935112000

Outcome results